Hepcidin and IL-1β.


Journal

Vitamins and hormones
ISSN: 0083-6729
Titre abrégé: Vitam Horm
Pays: United States
ID NLM: 0413601

Informations de publication

Date de publication:
2019
Historique:
entrez: 26 2 2019
pubmed: 26 2 2019
medline: 6 6 2019
Statut: ppublish

Résumé

Hepcidin expression is determined through transcriptional regulation by systemic iron status. However, acute or chronic inflammation also increases the expression of hepcidin, which is associated with the dysregulation of iron metabolism in pathological conditions. Interleukin (IL)-6 has been suggested to be a principal molecule to confer inflammation-related hepcidin transcription, which is mediated via signal transducer and activator of transcription (STAT)-binding site on the hepcidin promoter. Recently, it has been uncovered that another pro-inflammatory cytokine IL-1β stimulates hepcidin expression through the distinct mechanism underlying IL-6-mediated hepcidin transcription. In addition to IL-6 induction, IL-1β stimulates expression of CCAAT-enhancer-binding protein (C/EBP)δ, a transcription factor, leading to transcriptional activation of hepcidin via C/EBP-binding site on the hepcidin promoter. Thus, hepcidin transcription is stimulated through multiple elements in response to proinflammatory cytokines. Relationships between increased production of IL-1β and dysregulated iron metabolism have been suggested in various diseases, which may be linked to overproduction of hepcidin.

Identifiants

pubmed: 30798809
pii: S0083-6729(19)30007-X
doi: 10.1016/bs.vh.2019.01.007
pii:
doi:

Substances chimiques

Hepcidins 0
Interleukin-1beta 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

143-156

Informations de copyright

© 2019 Elsevier Inc. All rights reserved.

Auteurs

Yohei Kanamori (Y)

Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.

Masaru Murakami (M)

Laboratory of Molecular Biology, Azabu University School of Veterinary Medicine, Sagamihara, Japan.

Makoto Sugiyama (M)

Laboratory of Veterinary Anatomy, Kitasato University School of Veterinary Medicine, Towada, Japan.

Osamu Hashimoto (O)

Laboratory of Experimental Animal Science, Kitasato University School of Veterinary Medicine, Towada, Japan.

Tohru Matsui (T)

Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan.

Masayuki Funaba (M)

Division of Applied Biosciences, Graduate School of Agriculture, Kyoto University, Kyoto, Japan. Electronic address: mfunaba@kais.kyoto-u.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH